Study provides insight into link between two rare tumor syndromes

August 22, 2017 by Reggie Kumar, University of California, Los Angeles
Image of a mouse brain shows a rhabdoid tumor (the darker area at right). Credit: Jeremie Vitte/UCLA Jonsson Comprehensive Cancer Center

UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation can also cause a benign tumor condition in humans in adulthood.

The scientists found that when one suppressor gene is turned off or inactivated during early stages of a developing mouse embryo, it induces the formation of a . The research demonstrates that this type of malignant tumor will not form if the gene is inactivated during later stages of nerve development. However, when combined with the inactivation of a second tumor suppressor, non-cancerous tumors develop in older mice.

The research, led by Dr. Marco Giovannini, a member of UCLA's Jonsson Comprehensive Cancer Center and senior author of the study, is the first of its kind to analyze the functional role of mutations in a mouse model with both known as SMARCB1 and NF2.

A tumor predisposition syndrome is a genetic disorder in which inherited genetic mutations predispose the affected individuals to the development of multiple tumors. People who carry SMARCB1 gene mutations are predisposed to either rhabdoid tumor predisposition syndrome or familial schwannomatosis syndrome, but the mechanisms causing one or the other disease are still unknown.

The rhabdoid tumor predisposition syndrome affects infants and toddlers who develop malignant, highly aggressive tumors mainly in the brain, spinal cord, kidney and other soft tissues. Treatment for rhabdoid tumors involves surgery and chemotherapy, but patients have a poor prognosis.

Adults with SMARCB1 gene mutations are at higher risk of developing familial schwannomatosis, typically developing non-cancerous schwannoma tumors, which can affect any nerves inside the human body. Symptoms can include painful lumps or tingling and numbness that are treated with surgery. 

Giovannini and his colleagues used genetically modified mice to induce different gene mutations during development of rhabdoid and schwannoma tumors. The researchers also found that malignant tumors in this mouse model had very similar molecular features to human rhabdoid tumors.

The study's findings will be used to refine and develop new therapies and treatments, which could benefit young children and adults with these tumor syndromes.

Explore further: Researchers find key gene in childhood cancer

More information: Jeremie Vitte et al. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development, Nature Communications (2017). DOI: 10.1038/s41467-017-00346-5

Related Stories

Researchers find key gene in childhood cancer

May 5, 2011
(BRONX, NY) – There are no effective treatments for rhabdoid tumors – aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare ...

A tumor-suppressing gene can be harmful in some cancers

August 16, 2017
The TET2 tumor suppressor gene helps guard against blood cancers and perhaps protects against heart disease. Mutations in the gene affect about 1% of people over the age of 65, making them more susceptible to those diseases. ...

Molecular signature for aggressive brain tumor uncovered

November 10, 2016
Meningiomas are the most common primary brain tumors, but the term encompasses over a dozen subtypes that range from benign to highly aggressive. Rhabdoid meningiomas are classified as highly aggressive due to their high ...

Loss of key protein unleashes cascade that culminates in rhabdoid tumor formation

December 13, 2016
Rhabdoid tumors are among the most recalcitrant childhood cancers, and scientists have long sought ways to understand what drives their resilience and makes them impervious to treatment.

Using fruit flies to study cancer: Scientists investigate childhood tumors

January 30, 2017
A team of Florida State University researchers has discovered that a common household pest can tell us a lot about an aggressive tumor that attacks young children.

Genetic mutations help brain tumors evade targeting by immunotherapy treatments

March 20, 2017
Tumors of the brain and spinal cord, or gliomas, are among the most commonly occurring brain tumors. Although a majority of gliomas are classified as curable, these low-grade tumors have the potential to develop more aggressive ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.